Get In Touch

Rising prevalence of geriatric population, cardiovascular diseases, and blood disorders are contributing to high adoption rate of coagulation testing. Further, high demand for point of care (POC) coagulation testing and technological advancement in the coagulation testing is adding to growth of the market.

As per market analysts, blood coagulation testing market is anticipated to grow at a lucrative rate due to development of healthcare infrastructure coupled with increased healthcare expenditure.

Meanwhile, nowadays people are involved in preventive healthcare rather than proactive healthcare. Hence, people are undergoing medical tests periodically.  This, in turn, is fuelling the demand for haemostasis analyzers.

Registering the trend, the players are also focussing on providing quality testing kits.

Moreover, rapid expansion of healthcare infrastructure in developed and emerging economies is one of the key driving factors aiding to growth of the market. Availability of advanced coagulation testing kit, with ability to conduct tests with high accuracy is another major driving factor.  

Favourable government policies favouring best healthcare delivery in several region is promoting the use of such kits.

On the other hand, high cost of such devices is likely to limit adoption rate. Further, strict regulations for approval of testing devices are restraining the growth of the market.

However, rising demand for disposable coagulation testing equipment is presenting lucrative growth opportunities in near future.

Distribution channels are playing significant role in expansion of the coagulation testing market. The kit is easily available at offline drug stores. Meanwhile, emerging e-commerce platforms is enhancing visibility of the product.

Cost-effectiveness and highly reliable kits are likely to spur the market growth in coming years.

Coagulation Testing Market: Snapshot

Blood testing measuring the blood’s ability to clot and the time taken for the same is known as coagulation testing. Clotting disorders can cause excessive bleeding or clotting and can thus be fatal in either scenario. Coagulation testing is ordered if the physician suspects clotting disorders. There are a number of bleeding disorders which are either acquired or inherited, the most common among them being hemophilia, blood factor deficiency, etc.

The global market for coagulation testing was worth US$1,730 million in 2016, and is expected to exhibit a solid 9% CAGR in the 2017-2025 forecast period to end up at a valuation of US$3,715.8 million.

Bleeding disorders can cause abnormal bleeding, therefore it is of the utmost importance to diagnose the disorders and monitor the coagulation status. The global coagulation testing market is witnessing significant growth due to growing prevalence of blood clotting disorders in many regions and the rise in cardiovascular disorders, which can also require regular coagulation testing.

coagulation testing market

PT Testing Likely to Dominate Coagulation Testing Market

The global coagulation testing market is segmented on the basis of product type into instruments and consumables. Consumables accounted for over 80% of the global coagulation testing market in 2016. The segment is anticipated to dominate the coagulation testing market throughout the forecast period. On the basis of test type, the coagulation testing market is segmented into PT, APTT, TT, ACT, and others. The PT test segment accounted for the highest share, accounting for over 70% of the coagulation testing market in 2016.

Based on end user, the global market is segmented into hospitals and clinics, diagnostic laboratories, home care settings and others. The diagnostic laboratories segment is anticipated to expand at a fast CAGR of close to 10% during the forecast period, while hospitals and clinics are likely to remain the leading contributor to the coagulation testing market.

APAC to Exhibit Rapid CAGR despite Dominance of North America, Europe

Geographically, North America and Europe are the major regions where revenue is derived from coagulation testing. The U.S., the U.K., and Germany show high adoption rates of coagulation testing instruments such as analyzers, POC testing PT monitors, etc. due to rise in awareness amongst people about the importance of detecting and monitoring their coagulation status, high prevalence of cardiovascular diseases, and the availability of a favorable reimbursement scenario. The coagulation testing market is likely to be valued at more than US$1 bn in both North America and Europe by 2025, with the two being valued at US$678.2 mn and US$569.2 mn in 2016, respectively.

The coagulation testing market in Asia Pacific is said to be at a primary stage. It is anticipated that Asia Pacific will gain significant market share over the forecast period. Some of the key driving forces for coagulation testing market in emerging countries in the region are rising awareness, increasing population, entry of new players focusing on emerging markets, and increase in healthcare funding. The Asia Pacific market for coagulation testing is expected to exhibit a robust 10.8% CAGR over the 2017-2025 forecast period, rising from a 2016 valuation of US$358.1 mn to US$891.8 mn by 2025.

Some of the key players in the global coagulation testing market are Alere Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens Healthineers, SYSMEX CORPORATION, Universal Biosensors, Inc., HemoSonics, LLC, and Helena Laboratories, Inc. Testing with high specificity and accuracy is likely to remain a major factor in the global coagulation testing market.

Global Coagulation Testing Market: Overview

This report provides forecast and analysis of the coagulation testing market on the global and regional levels. It provides historical data of 2016 along with forecast from 2017 to 2025 in terms of revenue (US$ Mn). The report also includes macroeconomic indicators along with an outlook on coagulation testing globally. It includes drivers and restraints of the coagulation testing market and their impact on each region during the forecast period. The report also comprises of the study of current issues with end users and opportunities for coagulation testing manufacturers in the global market.

In order to provide users with comprehensive view of the market, we have included detailed competitive analysis and market players with unique selling propositions. The competitive dashboard included in the report provides detailed comparison of coagulation testing manufacturers on parameters such as product offerings, revenue, key strategies, and recent developments. The study encompasses market attractiveness analysis, by product type, by test type, by end users and region.

Global Coagulation Testing Market: Segmentation

The report includes revenue generated from sales of coagulation testing in all regions and important countries in the regions. By product type, the global coagulation testing market has been segmented into instruments and consumables. On the basis of test type the coagulation testing market is segmented into PT, APTT, TT, ACT and others. On the basis of end users, the global coagulation testing market is segmented into hospitals and clinics, diagnostics laboratories, home care settings and others. Geographically, the market is segmented into regions viz. North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Global Coagulation Testing Market: Scope and Research Methodology

Market value for global coagulation testing have been estimated based on utility of coagulation testing for all product types. The revenue is forecasted through regional pricing trends. Market size and forecast for each segment have been provided in the context of global and regional markets. The coagulation testing market has been analyzed based on expected demand. Most of the key end users have been considered and potential applications have been estimated on the basis of secondary sources and feedback from primary respondents. Regional demand patterns have been considered while estimating the market for various end users of coagulation testing in different regions. Top-down approach has been used to estimate the coagulation testing market size, and bottom-up approach has been used to validate the market number. The market has been forecasted based on constant currency rates. A number of secondary sources consulted during the course of the study include Factiva, NCBI, Google books, company annual reports, websites, white papers, and publications.

Global Coagulation Testing Market: Competitive Dynamics

The report provides detailed competitive dashboard and company profiles of key participants operating in the global market. Some of the key players in the global coagulation testing market include Alere Inc., F. Hoffmann-La Roche Ltd., Abbott Laboratories, Siemens healthineers, SYSMEX CORPORATION, Universal Biosensors, Inc., HemoSonics, LLC, Helena Laboratories, Inc. and others.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Global Coagulation Testing market is segmented as below:

By Product Type

  • Instruments
  • Consumables

By Test Type

  • PT
  • APTT
  • TT
  • ACT
  • Others

By End Users

  • Hospitals and Clinics
  • Diagnostics Laboratories
  • Home Care Settings
  • Others

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.

TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.

Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:

Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.

Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.

Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Coagulation Testing Market

4. Market Overview
     4.1. Introduction
             4.1.1. Product Definition
     4.2. Market Dynamics
             4.2.1. Drivers
                        4.2.1.1. Economic Drivers
                        4.2.1.2. Supply Side Drivers
                        4.2.1.3. Demand Side Drivers
             4.2.2. Restraints
             4.2.3. Opportunities
             4.2.4. Key Trends

5. Global Coagulation Testing Market Analysis and Forecast, 2017-2025
     5.1. Market Revenue Projections (US$ Mn)
     5.2. Porter’s Five forces Analysis: Global Coagulation Testing Market
     5.3. Recent Development (Industry Updates, Merger & Acquisition) 
     5.4. Types of Blood Clotting Disorders
     5.5. Coagulation Pathways
     5.6. Future Market Outlook

6. Global Coagulation Testing Market Analysis and Forecast, By Product Type
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Market Value (US$ Mn) Forecast By Product Type
             6.3.1. Instruments
             6.3.2. Consumables
     6.4. Market Attractiveness By Product Type

7. Global Coagulation Testing Market Analysis and Forecast, By Test Type
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Market Value (US$ Mn) Forecast By Test Type
             7.3.1. PT
             7.3.2. APTT
             7.3.3. TT
             7.3.4. ACT
             7.3.5. Others 
     7.4. Market Attractiveness By Test Type

8. Global Coagulation Testing Market Analysis and Forecast, By End User
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Market Value (US$ Mn) Forecast By End User
             8.3.1. Hospitals and Clinics
             8.3.2. Diagnostic Laboratories
             8.3.3. Home Care Settings
             8.3.4. Others 
     8.4. Market Attractiveness By End User

9. Global Coagulation Testing Market Analysis and Forecasts, By Region
     9.1. Key Findings
     9.2. Market Value (US$ Mn) Forecast By Region
             9.2.1. North America
             9.2.2. Europe
             9.2.3. Asia Pacific
             9.2.4. Latin America
             9.2.5. Middle East and Africa
     9.3. Market Attractiveness By Region

10. North America Coagulation Testing Market Analysis and Forecast
     10.1. Key Findings
     10.2. Market Value (US$ Mn) Forecast By Product Type
             10.2.1. Instruments
             10.2.2. Consumables
     10.3. Market Value (US$ Mn) Forecast By Test Type
             10.3.1. PT
             10.3.2. APTT
             10.3.3. TT
             10.3.4. ACT
             10.3.5. Others 
     10.4. Market Value (US$ Mn) Forecast By End User
             10.4.1. Hospitals and Clinics
             10.4.2. Private Diagnostic Laboratories
             10.4.3. Home Care Settings
             10.4.4. Others 
     10.5. Market Value (US$ Mn) Forecast By Country
             10.5.1. U.S.
             10.5.2. Canada
     10.6. Market Attractiveness Analysis 
             10.6.1. By Product Type
             10.6.2. By Test Type
             10.6.3. By End User
             10.6.4. By Country

11.  Europe Coagulation Testing Market Analysis and Forecast
     11.1. Key Findings
     11.2. Market Value (US$ Mn) Forecast By Product Type
             11.2.1. Instruments
             11.2.2. Consumables
     11.3. Market Value (US$ Mn) Forecast By Test Type
             11.3.1. PT
             11.3.2. APTT
             11.3.3. TT
             11.3.4. ACT
             11.3.5. Others 
     11.4. Market Value (US$ Mn) Forecast By End User
             11.4.1. Hospitals and Clinics
             11.4.2. Diagnostic Laboratories
             11.4.3. Home Care Settings
             11.4.4. Others 
     11.5. Market Value (US$ Mn) Forecast By Country
             11.5.1. Germany
             11.5.2. U.K.
             11.5.3. France
             11.5.4. Spain
             11.5.5. Italy
             11.5.6. Rest of Europe
     11.6. Market Attractiveness Analysis 
             11.6.1. By Product Type
             11.6.2. By Test Type
             11.6.3. By End User
             11.6.4. By Country

12. Asia Pacific Coagulation Testing Market Analysis and Forecast
     12.1. Key Findings
     12.2. Market Value (US$ Mn) Forecast By Product Type
             12.2.1. Instruments
             12.2.2. Consumables
     12.3. Market Value (US$ Mn) Forecast By Test Type
             12.3.1. PT
             12.3.2. APTT
             12.3.3. TT
             12.3.4. ACT
             12.3.5. Others 
     12.4. Market Value (US$ Mn) Forecast By End User
             12.4.1. Hospitals and Clinics
             12.4.2. Diagnostic Laboratories
             12.4.3. Home Care Settings
             12.4.4. Others 
     12.5. Market Value (US$ Mn) Forecast By Country
             12.5.1. China
             12.5.2. Japan
             12.5.3. India
             12.5.4. Australia & New Zealand
             12.5.5. Rest of Asia Pacific
     12.6. Market Attractiveness Analysis 
             12.6.1. By Product Type
             12.6.2. By Test Type
             12.6.3. By End User
             12.6.4. By Country

13. Latin America Coagulation Testing Market Analysis and Forecast
     13.1. Key Findings
     13.2. Market Value (US$ Mn) Forecast By Product Type
             13.2.1. Instrument
             13.2.2. Consumables
     13.3. Market Value (US$ Mn) Forecast By Test Type
             13.3.1. PT
             13.3.2. APTT
             13.3.3. TT
             13.3.4. ACT
             13.3.5. Others 
     13.4. Market Value (US$ Mn) Forecast By End User
             13.4.1. Hospitals and Clinics
             13.4.2. Diagnostic Laboratories
             13.4.3. Home Care Settings
             13.4.4. Others 
     13.5. Market Value (US$ Mn) Forecast By Country
             13.5.1. Brazil
             13.5.2. Mexico
             13.5.3. Rest of Latin America
     13.6. Market Attractiveness Analysis 
             13.6.1. By Product Type
             13.6.2. By Test Type
             13.6.3. By End User
             13.6.4. By Country

14. Middle East and Africa Coagulation Testing Market Analysis and Forecast
     14.1. Key Findings
     14.2. Market Value (US$ Mn) Forecast By Product Type
             14.2.1. Instruments
             14.2.2. Consumables
     14.3. Market Value (US$ Mn) Forecast By Test Type
             14.3.1. PT
             14.3.2. APTT
             14.3.3. TT
             14.3.4. ACT
             14.3.5. Others 
     14.4. Market Value (US$ Mn) Forecast By End User
             14.4.1. Hospitals and Clinics
             14.4.2. Private Diagnostic Laboratories
             14.4.3. Home Care Settings
             14.4.4. Others 
     14.5. Market Value (US$ Mn) Forecast By Country
             14.5.1. Saudi Arabia
             14.5.2. South Africa
             14.5.3. Rest of MEA
     14.6. Market Attractiveness Analysis 
             14.6.1. By Product Type
             14.6.2. By Test Type
             14.6.3. By End User
             14.6.4. By Country

15.  Competition Landscape
     15.1. Market Player – Competition Matrix 
     15.2. Market Share Analysis By Company (2016)
     15.3. Company Profiles
             15.3.1. F. Hoffmann-La Roche Ltd.
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.2. Abbott Laboratories 
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.3. Siemens Healthineers 
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.4. SYSMEX CORPORATION 
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio5
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.5. Universal Biosensors, Inc.
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.6. HemoSonics, LLC
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.7. Thermo Fisher Scientific, Inc.
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.8. Helena Laboratories, Inc.
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.9. Alere Inc.
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.10.  Randox Laboratories Ltd.
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.11.  HORIBA, Ltd
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.12.  Agappe Diagnostics Ltd.
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview
             15.3.13.  Medtronic plc
                        15.3.1.1 Company Overview (HQ, Business Segments, Employee Strength)
                        15.3.1.2 Product Portfolio
                        15.3.1.3 SWOT Analysis
                        15.3.1.4 Financial Overview
                        15.3.1.5 Strategic Overview

List of Tables

Table 01: Acronyms Used
Table 02: Global Coagulation Testing  Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 03: Global Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types, 2015–2025 
Table 04: Global Coagulation Testing Market Size (US$ Mn) Forecast, by End Users, 2015–2025
Table 05: Global coagulation testing Market Size (US$ Mn) Forecast, by Region, 2015–2025 
Table 06: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025 
Table 07: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 08: North America Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 09: North America Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 10: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 11: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 12: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 13: Europe Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025 
Table 14: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 15: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 16: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 17: Asia Pacific Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 18: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 19: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 20: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 21: Latin America Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025
Table 22: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Product Type, 2015–2025
Table 23: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Test Types,2015–2025
Table 24: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by End Users, 2015–2025
Table 25: Middle East & Africa Coagulation Testing Market Value (US$ Mn) Forecast, by Country, 2015–2025

List of Figures

Figure 01: Global Coagulation Testing Market By Test types, Market Size (US$ Mn), 2016 (A)
Figure 02: Global Coagulation Testing Market Revenue (%), by End Users, 2016 (A)
Figure 03: Distribution of Coagulation Testing Market by Region, 2016 and 2025
Figure 04: Global Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 05: Porter’s Five Forces Analysis
Figure 06: Market Value Share, by Product Type (2016)
Figure 07: Market Value Share, by Test Types (2016)
Figure 08: Market Value Share, by End Users(2016)
Figure 09: Global Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 10: Global Coagulation Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Instruments, 2015–2025
Figure 11: Global Coagulation Testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Consumables, 2015–2025
Figure 12: Global Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 13: Global Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025 
Figure 14: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), PT test, 2015–2025
Figure 15: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by APTT Test, 2015–2025
Figure 16: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by TT Test, 2015–2025
Figure 17: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by ACT test, 2015–2025
Figure 18: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 19: Global Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 20: Global coagulation testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 21: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital and Clinics, 2015–2025
Figure 22: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories, 2015–2025
Figure 23: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Home care settings, 2015–2025
Figure 24: Global coagulation testing Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2015–2025
Figure 25: Global coagulation testing Market Attractiveness Analysis, by End Users, 2017–2025
Figure 26: Global Coagulation Testing Market Scenario
Figure 27: Global coagulation testing Market Value Share Analysis, by Region, 2016 and 2025
Figure 28: Global coagulation testing Market Attractiveness Analysis, by Region
Figure 29: North America Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 30: North America Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 31: North America Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 32: North America Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 33: North America Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 34: North America Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 35: North America Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 36: North America Coagulation Testing Market Attractiveness Analysis, by End Users 
Figure 37: North America Market Attractiveness Analysis, by Country
Figure 38: Europe Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 39: Europe Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 40: Europe Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 41: Europe Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 42: Europe Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 43: Europe Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 44: Europe Coagulation Testing Market Attractiveness Analysis, by Test Type
Figure 45: Europe Coagulation Testing Market Attractiveness Analysis, by End Users
Figure 46: Europe Market Attractiveness Analysis, by Country
Figure 47: Asia Pacific Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 48: Asia Pacific Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 49: Asia Pacific Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 50: Asia Pacific Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 51: Asia Pacific Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 52: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 53: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 54: Asia Pacific Coagulation Testing Market Attractiveness Analysis, by End Users 
Figure 55: Asia Pacific Market Attractiveness Analysis, by Country
Figure 56: Latin America Coagulation Testing Market Size (US$ Mn) Forecast, 2017–2025eval
Figure 57: Latin America Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 58: Latin America Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 59: Latin America Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 60: Latin America Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 61: Latin America Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 62: Latin America Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 63: Latin America Coagulation Testing Market Attractiveness Analysis, by End Users 
Figure 64: Latin America Market Attractiveness Analysis, by Country
Figure 65: Middle East & Africa Coagulation Testing Market Size (US$ Mn) Forecast, 2015–2025
Figure 66: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Product Type, 2016 and 2025
Figure 67: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Test Types, 2016 and 2025
Figure 68: Middle East & Africa Coagulation Testing Market Value Share Analysis, by End Users, 2016 and 2025
Figure 69: Middle East & Africa Coagulation Testing Market Value Share Analysis, by Country, 2016 and 2025
Figure 70: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Product Type
Figure 71: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by Test Types
Figure 72: Middle East & Africa Coagulation Testing Market Attractiveness Analysis, by End Users
Figure 73: Middle East & Africa Market Attractiveness Analysis, by Country
Figure 74: Global Coagulation Testing Market Share Analysis, by Company (2016)
Figure 75: Breakdown of Net Sales, by Segment, 2016,(F. Hoffmann-La Roche)
Figure 76: Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016, ,(F. Hoffmann-La Roche)

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Request Customization

Coagulation Testing Market